Inbox Robot - Choose newsletter content

Choose content

Enter keywords to create a newsletter

Create account

Enter your registration information

Set preferences

Set up your newsletter name, delivery and time zone preferences

Hint: Enter different keywords to generate new results.

Now you can:

Search the news index.
Browse more than 1 million newsletters by category.
Use preset newsletters:
- Multiple Myeloma
- Multiple Myeloma Drugs

Multiple Myeloma Newsletter

<![CDATA[AQUILA Trial: Closing the Care Gap in High-Risk Smoldering Multiple Myeloma]]> 03 Dec 2025 04:47 GMT
… gap in high-risk smoldering multiple myeloma (HR-SMM) that the phase … to the development of active multiple myeloma (MM), rather than upon or …
Conflicting Guidance and Rapid Innovation Leave Physicians Seeking Clarity in Relapsed/Refractory Multiple Myeloma 02 Dec 2025 22:10 GMT
… ) -- “Relapsed/Refractory Multiple Myeloma (RRMM) is difficult to manage … Insights’ newly published Market Dynamix™: Multiple Myeloma (US) 2025 report, captures … of unprecedented therapeutic expansion in multiple myeloma – especially within the relapsed…
Multiple myeloma group meets in Rehoboth 01 Dec 2025 15:57 GMT
Delaware Multiple Myeloma Support Group meeting attendees shown …
<![CDATA[Evolutions Across NSCLC, Multiple Myeloma, and AML at Georgia Cancer Center]]> 01 Dec 2025 13:57 GMT
… –small cell lung cancer (NSCLC), multiple myeloma, and acute myeloid leukemia (AML … for mitigating current challenges in multiple myeloma care. She emphasized fostering collaborative …
<![CDATA[Dr Jakubowiak on the Efficacy of KRd Maintenance Therapy Post-ASCT in Multiple Myeloma]]> 28 Nov 2025 20:42 GMT
… the treatment of patients with multiple myeloma who have already received autologous … benefit are generally rare in multiple myeloma, Jakubowiak concluded.
CAR T-Cell Therapy for the Multiple Myeloma Market, 2025-2035: Extensive Data on Products, End Users, Regions and Companies - ResearchAndMarkets.com 28 Nov 2025 17:18 GMT
… patients with relapsed or refractory multiple myeloma (RRMM). Building upon traditional … the rising global incidence of multiple myeloma, particularly among aging populations, is … CAR T-Cell Therapy for Multiple Myeloma market faces several significant …
Hong Kong Department of Health approves IASO Bio’s’ Fucaso to treat relapsed or refractory multiple myeloma 28 Nov 2025 08:50 GMT
… patients with relapsed or refractory multiple myeloma (R/R MM) who …
With site 'irregularities,' Bristol Myers delays key Cobenfy readout in Alzheimer's psychosis 03 Dec 2025 15:49 GMT
… dual primary endpoints in a multiple myeloma trial of iberdomide. Alzheimer’s …
ImpriMed to Present Ex Vivo Drug Sensitivity Data in Acute Myeloid Leukemia in Oral Presentation at American Society of Hematology Annual Meeting 03 Dec 2025 17:48 GMT
… leukemia, non-Hodgkin lymphoma, and multiple myeloma. ImpriMed operates two laboratories: the …
Sarah Cannon Research Institute to Present Research on Advances in Blood Cancers and Blood Disorders at 2025 ASH Annual Meeting & Exposition 03 Dec 2025 12:50 GMT
… , SCRI, will moderate the session, Multiple Myeloma: Pharmacologic Therapies: Advances in Treatment … Strategies for Relapsed/Refractory Multiple Myeloma, on Saturday, December 6 at …

Satisfied with the content?

Continue to create your account.

Choose content

Create account

Set preferences

EIN MARKETING SOLUTIONS

EIN NEWS SERVICES

ALL NEWS PUBLICATIONS